A Multicenter Study of CAR-T Cells in Primary Ph+All
NCT07252336
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
ALL
Interventions
DRUG:
CD19 CAR-T cells
Sponsor
Zhejiang University
Collaborators
[object Object]